AAAAAA
Results: 1-25/30
Authors:
Li, GL
Danhof, M
Bouwstra, JA
Citation: Gl. Li et al., Iontophoretic delivery of apomorphine in vitro: Physicochemic considerations, PHARM RES, 18(11), 2001, pp. 1509-1513
Authors:
Li, GL
Danhof, M
Bouwstra, JA
Citation: Gl. Li et al., Effect of elastic liquid-state vesicle on apomorphine iontophoresis transport through human skin in vitro, PHARM RES, 18(11), 2001, pp. 1627-1630
Authors:
Zuideveld, KP
Maas, HJ
Treijtel, N
Hulshof, J
Van der Graaf, PH
Peletier, LA
Danhof, M
Citation: Kp. Zuideveld et al., A set-point model with oscillatory behavior predicts the time course of 8-OH-DPAT-induced hypothermia, AM J P-REG, 281(6), 2001, pp. R2059-R2071
Authors:
Vis, P
Della Pasqua, O
Kruk, M
Martin, D
Mocaer, E
Danhof, M
Jochemsen, R
Citation: P. Vis et al., Population pharmacokinetic-pharmacodynamic modelling of S 15535, a 5-MT1A receptor agonist, using a behavioural model in rats, EUR J PHARM, 414(2-3), 2001, pp. 233-243
Authors:
Parker, TJ
Della Pasqua, OE
Loizillon, E
Chezaubernard, C
Jochemsen, R
Danhof, M
Citation: Tj. Parker et al., Pharmacokinetic-pharmacodynamic modelling in the early development phase of anti-psychotics: A comparison of the effects of clozapine, S 16924 and S 18327 in the EEG model in rats, BR J PHARM, 132(1), 2001, pp. 151-158
Authors:
Visser, SAG
Smulders, CJGM
Gladdines, WWFT
Irth, H
van der Graaf, PH
Danhof, M
Citation: Sag. Visser et al., High-performance liquid chromatography of the neuroactive steroids alphaxalone and pregnanolone in plasma using dansyl hydrazine as fluorescent label: application to a pharmacokinetic-pharmacodynamic study in rats, J CHROMAT B, 745(2), 2000, pp. 357-363
Authors:
Zuideveld, KP
Treijtel, N
Van der Graaf, PH
Danhof, M
Citation: Kp. Zuideveld et al., Enantioselective high-performance liquid chromatographic analysis of the 5-HT1A receptor agonist 8-hydroxy-2(di-n-propylamino)tetralin - Application to a pharmacokinetic-pharmacodynamic study in rats, J CHROMAT B, 738(1), 2000, pp. 67-73
Authors:
Eckland, DA
Danhof, M
Citation: Da. Eckland et M. Danhof, Clinical pharmacokinetics of pioglitazone, EXP CL E D, 108, 2000, pp. S234-S242
Authors:
Cleton, A
Altorf, BA
Voskuyl, RA
Danhof, M
Citation: A. Cleton et al., Pharmacokinetic-pharmacodynamic modelling of tiagabine CNS effects upon chronic treatment in rats: lack of change in concentration-EEG effect relationship, EUR J PH SC, 12(2), 2000, pp. 141-150
Authors:
Della Paschoa, OE
Hoogerkamp, A
Edelbroek, PM
Voskuyl, RA
Danhof, M
Citation: Oe. Della Paschoa et al., Pharmacokinetic-pharmacodynamic correlation of lamotrigine, flunarizine, loreclezole, CGP40116 and CGP39551 in the cortical stimulation model, EPILEPSY R, 40(1), 2000, pp. 41-52
Authors:
Garrido, M
Gubbens-Stibbe, J
Tukker, E
Cox, E
von Frijtag, J
Kunzel, D
IJzerman, A
Danhof, M
van der Graaf, PH
Citation: M. Garrido et al., Pharmacokinetic-pharmacodynamic analysis of the EEG effect of alfentanil in rats following beta-funaltrexamine-induced mu-opioid receptor "knockdown"in vivo, PHARM RES, 17(6), 2000, pp. 653-659
Authors:
Cleton, A
Odman, J
Van der Graaf, PH
Ghijsen, W
Voskuyl, R
Danhof, M
Citation: A. Cleton et al., Mechanism-based modeling of functional adaptation upon chronic treatment with midazolam, PHARM RES, 17(3), 2000, pp. 321-327
Authors:
Santos, SR
Papini, O
Omosako, CE
Pereira, MD
Quintavalle, TBG
Riccio, MF
Kurata, A
Pereira, VA
Di-Pietro, G
Della-Paschoa, OE
Danhof, M
Da-Luz, PL
Citation: Sr. Santos et al., A simple HPLC-fluorescence method for the measurement of R,S-sotalol in the plasma of patients with life-threatening cardiac arrhythmias, BRAZ J MED, 33(2), 2000, pp. 199-204
Authors:
Knibbe, CAJ
Aarts, LPHJ
Kuks, PFM
Voortman, HJ
Lie-A-Huen, L
Bras, LJ
Danhof, M
Citation: Caj. Knibbe et al., Pharmacokinetics and pharmacodynamics of propofol 6% SAZN versus propofol 1% SAZN and Diprivan-10 for short-term sedation following coronary artery bypass surgery, EUR J CL PH, 56(1), 2000, pp. 89-95
Authors:
Karlsson, MO
Schoemaker, RC
Kemp, B
Cohen, AF
van Gerven, JMA
Tuk, B
Peck, CC
Danhof, M
Citation: Mo. Karlsson et al., A pharmacodynamic Markov mixed-effects model for the effect of temazepam on sleep, CLIN PHARM, 68(2), 2000, pp. 175-188
Authors:
Cleton, A
Altorf, BA
Voskuyl, RA
Danhof, M
Citation: A. Cleton et al., Effect of amygdala kindling on the central nervous system effects of tiagabine: EEG effects versus brain GABA levels, BR J PHARM, 130(5), 2000, pp. 1037-1044
Authors:
Knibbe, CAJ
Koster, VS
Aarts, LPHJ
Langemeijer, HJM
Danhof, M
Citation: Caj. Knibbe et al., Pilot study in humans on the pharmacokinetics and safety of propofol 6% SAZN, PHARM WORLD, 21(5), 1999, pp. 239-240
Authors:
Cleton, A
Van der Graaf, PH
Ghijsen, W
Voskuyl, R
Danhof, M
Citation: A. Cleton et al., Mechanism-based modeling of adaptive changes in the pharmacodynamics of midazolam in the kindling model of epilepsy, PHARM RES, 16(11), 1999, pp. 1702-1709
Authors:
Knibbe, CAJ
Voortman, HJ
Aarts, LPHJ
Kuks, PFM
Lange, R
Langemeijer, HJM
Danhof, M
Citation: Caj. Knibbe et al., Pharmacokinetics, induction of anaesthesia and safety characteristics of propofol 6% SAZN vs propofol 1% SAZN and Diprivan (R)-10 after bolus injection, BR J CL PH, 47(6), 1999, pp. 653-660
Authors:
Snoeck, E
Jacqmin, P
Van Peer, A
Danhof, M
Citation: E. Snoeck et al., A combined specific target site binding and pharmacokinetic model to explore the non-linear disposition of draflazine, J PHAR BIOP, 27(3), 1999, pp. 257-281
Authors:
Cleton, A
de Greef, HJMM
Edelbroek, PM
Voskuyl, RA
Danhof, M
Citation: A. Cleton et al., Application of a combined "effect compartment/indirect response model" to the central nervous system effects of tiagabine in the rat, J PHAR BIOP, 27(3), 1999, pp. 301-323
Authors:
Van der Graaf, PH
Van Schaick, EA
Visser, SAG
De Greef, HJMM
Ijzerman, AP
Danhof, M
Citation: Ph. Van Der Graaf et al., Mechanism-based pharmacokinetic-pharmacodynamic modeling of antilipolytic effects of adenosine A(1) receptor agonists in rats: Prediction of tissue-dependent efficacy in vivo, J PHARM EXP, 290(2), 1999, pp. 702-709
Authors:
Tuk, B
Van Oostenbruggen, MF
Herben, VMM
Mandema, JW
Danhof, M
Citation: B. Tuk et al., Characterization of the pharmacodynamic interaction between parent drug and active metabolite in vivo: Midazolam and alpha-OH-midazolam, J PHARM EXP, 289(2), 1999, pp. 1067-1074
Authors:
Van der Graaf, PH
Nilsson, J
Van Schaick, EA
Danhof, M
Citation: Ph. Van Der Graaf et al., Multivariate quantitative structure-pharmacokinetic relationships (QSPKR) analysis of adenosine A(1) receptor agonists in rat, J PHARM SCI, 88(3), 1999, pp. 306-312
Authors:
Cleton, A
de Greef, HJMM
Edelbroek, PM
Voskuyl, RA
Danhof, M
Citation: A. Cleton et al., Stereoselective central nervous system effects of the R- and S-isomers of the GABA uptake blocker N-(4,4-di-(3-methylthien-2-yl)but-3-enyl) nipecoticacid in the rat, BR J PHARM, 128(8), 1999, pp. 1651-1658